Clinical Trials Directory

Trials / Completed

CompletedNCT04407949

Comparison of Sleep Disordered Breathing Events Detected by the CPAP Device "prismaLine" With Polysomnography

Untersuchung Der Übereinstimmung Der Ereigniserkennung Von "prismaLine" Geräten Mit Der Polysomnographie

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
70 (actual)
Sponsor
Institut für Pneumologie Hagen Ambrock eV · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Evaluation of residual sleep disordered breathing (SDB) under continuous positive airway pressure (CPAP) therapy with comparison of the automatic detected SDB event indices from CPAP machines with manual scored polysomnography (PSG).

Detailed description

The evaluation of residual sleep disordered breathing (SDB) in sleep apnea (SA) after initiation of continuous positive airway pressure (CPAP) therapy is important to verify the therapeutic success. In clinical practice, the internal records of CPAP devices are utilized to determine the therapeutic success, during either medical consultations or telemetric observation. This study was designed to evaluate the quality of SDB Event Indices (EI), which are recorded by the CPAP device (Prisma, Löwenstein Medical Technology). The detected events of a manual scored polysomnography (PSG) in the sleep laboratory will be compared with the simultaneously recorded events of the CPAP device. This shall lead to recommendations regarding the situations, and in which degree the event detection of the CPAP devices may be meaningful to determine the therapeutic success of home sleep apnea therapy.

Conditions

Interventions

TypeNameDescription
OTHERCPAP TreatmentComparing events from the CPAP device with the events scored in PSG

Timeline

Start date
2019-01-17
Primary completion
2020-06-08
Completion
2020-09-30
First posted
2020-05-29
Last updated
2020-10-06

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT04407949. Inclusion in this directory is not an endorsement.